Bharathy Pavithra, Thanikachalam Punniyakoti V, Shoban Arundhamizh N, Himayavendhan Harish V
Department of Pharmaceutics, Saveetha College of Pharmacy, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, IND.
Department of Pharmaceutical Chemistry, Saveetha College of Pharmacy, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, IND.
Cureus. 2024 Sep 23;16(9):e70038. doi: 10.7759/cureus.70038. eCollection 2024 Sep.
and are known for their traditional medicinal uses due to their diverse phytochemicals and pharmacological effects, which have attracted the interest of many researchers. This study aims to evaluate the antioxidant, anti-inflammatory, and cytotoxic effects of their combined extracts.
In vitro antioxidant activity against reactive oxygen species (ROS) was measured using the ferric-reducing ability of plasma (FRAP), nitric oxide (NO), and 2,2-azino-bis-3-ethylbenzothiazoline-6-sulphonic acid (ABTS) assays, while anti-inflammatory effects were assessed via the membrane stabilization method. Docking studies were performed to evaluate the interaction of phytochemicals - anthocyanins, quercetin, and ursolic acid, which are present in these plants - with nuclear factor kappa B (NF-κB), cyclooxygenase-1 (COX-1), and cyclooxygenase-2 (COX-2). Standard protocols were used to evaluate embryotoxicity using the brine shrimp model and cytotoxicity using the zebrafish model, which is crucial for determining safe clinical dosages.
The analysis revealed diverse bioactive compounds, including anthocyanins, quercetin, and ursolic acid. The formulation effectively inhibited ROS production at lower concentrations (inhibitory concentration 50%, or IC50 value ~2.8 µg/mL), indicating their potential for managing oxidative stress. Quercetin demonstrated the strongest interaction with all tested proteins, particularly NF-kB. Cytotoxicity and embryotoxicity assays revealed a dose-dependent effect (lethal concentration 50%, or LC50 value 82.4 µg/mL), with no adverse effects on developing embryos at the tested doses (5-80 µg/mL), suggesting the extracts are safe for clinical use, even during pregnancy.
The combined extracts of and exhibit potent antioxidant and anti-inflammatory effects without causing cytotoxic or embryotoxic effects, even at higher concentrations. This indicates their potential for safe clinical application in treating oxidative and inflammatory diseases.
[植物名称1]和[植物名称2]因其多样的植物化学成分和药理作用而具有传统药用价值,这吸引了许多研究人员的关注。本研究旨在评估它们的联合提取物的抗氧化、抗炎和细胞毒性作用。
使用血浆铁还原能力(FRAP)、一氧化氮(NO)和2,2-联氮-双-3-乙基苯并噻唑啉-6-磺酸(ABTS)测定法测量对活性氧(ROS)的体外抗氧化活性,同时通过膜稳定法评估抗炎作用。进行对接研究以评估这些植物中存在的植物化学成分——花青素、槲皮素和熊果酸与核因子κB(NF-κB)、环氧化酶-1(COX-1)和环氧化酶-2(COX-2)的相互作用。使用标准方案通过卤虫模型评估胚胎毒性,并通过斑马鱼模型评估细胞毒性,这对于确定安全的临床剂量至关重要。
分析揭示了多种生物活性化合物,包括花青素、槲皮素和熊果酸。该制剂在较低浓度下(半数抑制浓度,即IC50值约为2.8μg/mL)有效抑制ROS产生,表明它们具有管理氧化应激的潜力。槲皮素与所有测试蛋白表现出最强的相互作用,尤其是与NF-κB。细胞毒性和胚胎毒性测定显示出剂量依赖性效应(半数致死浓度,即LC50值为82.4μg/mL),在所测试的剂量(5-80μg/mL)下对发育中的胚胎没有不良影响,表明提取物即使在怀孕期间临床使用也是安全的。
[植物名称1]和[植物名称2]的联合提取物即使在较高浓度下也表现出强大的抗氧化和抗炎作用,而不会引起细胞毒性或胚胎毒性作用。这表明它们在治疗氧化和炎症性疾病方面具有安全临床应用的潜力。